Severity of anemia during interferon and ribavirin therapy in patients with chronic active hepatitis c genotype-3 and its association with risk factors

ABSTRACT

Hepatitis C is a major public health problem globally. It is one of the commonest cause of chronic liver disease in Pakistan. The prevalent genotype is "3" in our country. The standard of care treatment is combination of interferon and ribavirin. This combination has important adverse effects especially hemolytic anemia